The expansion of Icon in eastern Europe is supported by increasing client demand to conduct trials in this emerging market, which provides high availability of patient volunteers
As part of the continuing expansion of its clinical research activity in eastern Europe, Icon has announced the opening of two new offices in Warsaw and Vilnius.
Commenting on the expansion, Peter Sowood, president of Icon clinical research in Europe, said: "The opening of Icon offices in these strategic eastern European countries complements our existing network of offices in Riga, Moscow and Budapest and strengthens our capabilities in what is an increasingly significant area for clinical research".
The expansion of Icon in eastern Europe is supported by increasing client demand to conduct trials in this emerging market.
Eastern Europe provides high availability of patient volunteers and a strong network of investigator sites, key factors in the management of clinical trials.
Sustained Icon success in the region has resulted in the company's decision to enhance its presence with the new office openings.
Both the Warsaw and Vilnius offices will offer the full range of Icon services and will support future drug development in the region.
